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Perturbations of stromal–epithelial interactions in the developing tumour can contribute to cancer invasion and metastasis. The
structurally related metallopeptidases endothelin-converting enzyme (ECE) and neutral endopeptidase (NEP) contribute sequentially
to the synthesis and inactivation of ET-1, a mitogenic peptide that has been shown to affect tumour behaviour. This study has
investigated the interaction between metastatic tumour epithelial cells, which lack NEP, and stromal cells, which we have shown to
express ECE-1 (stromal–epithelial interactions), using Matrigel invasion chambers. The epithelial cell lines utilised in this study include
androgen-sensitive LNCaP, androgen-independent PC-3, Du145 and recently established PNT-1a, PNT2-C2 and P4E6 prostate cell
lines. Specific inhibition of endogenous ECE-1 activity in stromal cells reduced PC-3 and Du145 invasion by 70 and 50%, respectively.
Addition of recombinant NEP to inactivate endogenous mitogenic peptides resulted in 50 and 20% reductions in invasion in PC-3 and
Du145 cells, respectively. Neutral endopeptidase effects were reversed in the presence of thiorphan, a specific NEP inhibitor.
Supplementation of defined media with bradykinin and ET-1 significantly increased PC-3 invasion by 40 and 50%, respectively. Du145
cell invasion increased by approximately 100% on adding ET-1. These studies implicate the metallopeptidases NEP and ECE-1 as
mediators of prostate cancer invasion via a stromal/epithelial interaction.
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The majority of tumour studies have focused on events occurring
within the malignant epithelial cells, which result in the disruption
of molecular pathways regulating essential functions such as
proliferation and invasion. More recently, studies have begun to
document changes in the stromal environment surrounding the
tumour (‘reactive stroma’) and its importance in promoting
invasion, progression and metastasis (Tuxhorn et al, 2001).
Human cancers have been found to generate a reactive stroma,
which can promote tumorigenesis and influence epithelial cell
invasion during in vitro modelling of prostate cancer invasion
(Lang et al, 2000). Stromal cells derived from malignant prostate
tissue can provide a greater stimulus for tumour cell invasion than
their nonmalignant counterparts, but nonmalignant stromal cells
can also influence the development and rate of human prostate
tumorigenesis in mouse xenograft models (Tuxhorn et al, 2002).
Clinical and preclinical data have indicated a mitogenic role for
small regulatory peptides such as endothelin-1 (ET-1), bradykinin,
bombesin-like peptides and neurotensin in various stages of
prostate cancer (Bologna et al, 1989; Papandreou et al, 1998).
Endothelin-1, in particular, has been demonstrated in prostatic
tissue in vivo and in human PC lines in vitro with plasma ET-1
concentrations significantly elevated in men with metastatic
disease (Nelson et al, 1995). Endothelin-1 can also synergise the
proliferative effects of other peptide growth factors in various
prostate cancer cell lines (Battistini et al, 1993). Active ET-1 is
generated from big-ET by endothelin-converting enzyme (ECE-1),
which can also inactivate bradykinin (Hoang and Turner, 1997).
Endothelin-converting enzyme-1 is a membrane-bound zinc-
dependent metallopeptidase of the M13 family, which also includes
the closely related peptidase, neutral endopeptidase (NEP, CALLA,
CD10) (Turner et al, 2001). Endothelin-converting enzyme-1 has a
broad tissue distribution and exists as four distinct isoforms
termed ECE-1a, ECE-1b, ECE-1c (Schweizer et al, 1997) and ECE-
1d (Valdenaire et al, 1999). These isoforms differ only in their N-
terminal regions and are derived from a single gene through the
use of alternative promoters. They have distinct subcellular
locations: ECE-1a and ECE-1c are found at the cell surface,
whereas ECE-1b and ECE-1d are reported to be located on
intracellular membrane compartments (Muller et al, 2003).
Neutral endopeptidase inactivates a range of regulatory
peptides, including ET-1 at the cell surface (Turner et al, 2001).
Neutral endopeptidase is expressed on benign prostate epithelial
cells but dramatically downregulated in metastatic human PC
(Papandreou et al, 1998), and contributes to the transition of
hormonally regulated androgen-dependent to independent PC
(Papandreou et al, 1998) both via enzymatic activity and by
nonenzymatic signalling interactions (Papandreou et al, 1998;
Sumitomo et al, 2000).
We have recently reported an inverse correlation between NEP
and ECE-1 expression in metastatic PC cell lines (Usmani et al,
2002). This study addresses the invasion-promoting properties of
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ystromal cells on epithelial components of prostate cancer as a
consequence of ECE and NEP expression. The purpose of this
study was to investigate the relevance of stromal ECE-1 expression
on the invasion of PC cells through Matrigel, by using stromal–
epithelial co-culture techniques, and to examine whether invasion
can be modulated using inhibitors of NEP and ECE-1.
MATERIALS AND METHODS
Materials
The ECE-1 monoclonal antibody AEC 32-236, which recognises all
ECE-1 isoforms (described by Shimada et al, 1994), was generously
donated by Dr K Tanzawa (Sankyo Research Laboratories, Tokyo).
The NEP monoclonal (NCL-CD10-270) was obtained from
Novocastra (Newcastle, UK). Recombinant NEP protein was a gift
from Dr David Nanus (Cornell University, New York, USA).
Primary cells (Lang et al, 1998) and P4E6, PNT1a, PNT2C2 cell
lines (Maitland et al, 2001) were provided by York Cancer Unit.
Matrigel, cell culture inserts and companion plates were obtained
from Becton and Dickinson (Bedford, UK). Peptides and thiorphan
were purchased from Sigma. The ECE-1 specific inhibitor, 4-
chloro-N-[(4-cyano-3-methyl-1-phenyl-1H-pyrazol-5-yl)amino]-
carbonyl]benzene sulphonamide monosodium salt, referred to
here as ECE-i, was described and characterised by Umekawa et al
(2000). Endothelin-1 was obtained from The Peptide Institute
(Barnet, UK).
Cell culture
Cell lines were routinely cultured in RPMI-1640 containing 2mML-
glutamine and 10% FBS with the following exceptions: P4E6 cells
were cultured in keratinocyte-SFM supplemented with bovine
pituitary extract (25mgml
1), recombinant epidermal growth
factor (rEGF: 0.2ngml
1), 2mML -glutamine and 2% FBS. The
mouse embryonic fibroblast cell line STO (Lang et al, 2001) was
maintained in DMEM containing 2mML -glutamine and 10%
(vv
1) FBS. All cells were routinely grown in antibiotic-free media
at 371C and 5% CO2. Primary stromal cells were maintained in
RPMI-1640 supplemented with 2mML-glutamine, 10% (vv
1) FBS,
1% (vv
1) penicillin and 50Unitsml
1 streptomycin. Primary
epithelial cells were maintained in keratinocyte serum-free
medium supplemented with 2mML -glutamine, bovine pituitary
extract (50mgml
1), rEGF (0.2ngml
1) and 1% (vv
1) penicillin
(50Unitsml
1) and streptomycin (50mgml
1). The above cell
culture reagents were all purchased from GIBCO BRL (UK).
Invasion assay
The invasion assay was performed essentially as described by Lang
et al (2000). The following supplements were added, either alone or
in combination, to both STO (stromal) cell (bottom well) and
epithelial cell (top well) media: NEP (50mgml
1), thiorphan
(1mM), bradykinin (100nM), ET-1 (10nM) and the specific ECE
inhibitor ECE-i (100nM). The invasion assay was incubated
overnight at 371C. Subsequently, the inserts were removed from
the wells, washed in PBS, fixed in 100% methanol for 10min and
stained with 0.1% (wv
1) Crystal Violet (Sigma). Cells that had
invaded to the underside of the inserts were counted by light
microscopy. Four fields of view from each insert were counted.
Two-tailed student T-tests were used to ascertain the statistical
significance with a threshold of Po0.05.
Immunofluorescence
Cells were grown to 60% confluency on sterile coverslips, washed
twice with PBS and fixed and permeabilised for 10min in
methanol/acetone 50:50 at room temperature. Nonspecific bind-
ing sites were blocked for 30min in blocking buffer (TBS,
1% (vv
1) normal goat serum and 0.2% (wv
1) gelatin). Primary
antibodies were used at the following concentrations: ECE-1
(1:100), NEP (1:80). For negative controls, the primary antibody
was replaced with pre-immune serum or IgG subclass antibody.
Cells were washed three times in TBS and incubated for 30min at
room temperature with FITC conjugated anti-mouse IgG (1:1000)
or FITC conjugated anti-rabbit IgG (1:1000) (Jackson ImmunoR-
esearch Laboratory). Cells were washed three times in TBS,
coverslips were inverted and mounted onto glass slides. Cells were
examined using an Olympus IX70 inverted wide-field fluorescence
microscope. Images were captured using Delta Vision from
Applied Precision.
Immunoblotting
Protein was isolated from membrane fractions from disrupted
cells using N2 gas in a Parr cell disruption bomb (750psi), resolved
by SDS–PAGE, transferred to a nitrocellulose membrane (Invitro-
gen) and blocked in 0.1% Tween-20 in 10mM Tris–HCl, pH 7.4
(TBST) with 5% (wv
1) milk powder. Membrane proteins were
incubated with the following antibodies: ECE-1 (1:500) and NEP
(1:100). Specific protein bands were detected using ECL reagents
(Amersham Pharmacia).
RESULTS
NEP and ECE-1 protein expression in PC cell lines
Previous data (Usmani et al, 2002) have shown that high levels of
NEP protein are expressed in LNCaP cells, whereas metastatic PC-3
and Du145 display low levels. In contrast, LNCaP cells have low
ECE-1 protein expression while PC-3 and Du145 show compara-
tively high levels. A contrast in NEP and ECE expression is also
evident in the transformed cell lines where PNT-1a cells show
staining for NEP, whereas PNT2-C2 and P4E6 express ECE-1
protein. STO cells express comparatively high levels of ECE-1
(Figure 1B) but do not express NEP (Figure 1A).
Subcellular localisation of NEP and ECE-1 protein
Immunofluorescence analysis was used to investigate the sub-
cellular distribution of NEP and ECE-1 protein in PC-3, Du145 and
STO cells. Immunostaining of methanol/acetone-fixed STO cells
revealed no staining with NEP (not shown), but bright diffuse
staining with ECE-1 (Figure 1C). In PC-3 cells, ECE-1 protein
staining was seen as a bright surface membrane and cytoplasmic
fluorescence (Figure 1D), whereas Du145 revealed punctate
staining throughout the cytoplasm (Figure 1E). Neither of the
metastatic cells stained positive for NEP. In contrast, LNCaP cells
revealed no staining with ECE-1 (not shown), but NEP protein
staining was revealed predominantly at the cell surface (Figure 1F).
PC cell invasion through Matrigel
The influence of stromal cells (STO) on the ability of the PC cell
lines to invade Matrigel was measured using indirect co-culture.
The data show that PC invasion is increased in the presence of
stromal cells. PC-3 and Du145 were the most invasive in
comparison to the transformed prostate epithelial cells lines,
PNT-1a, PNT2-C2 and P4E6, which showed much less invasion
both in the presence or the absence of stromal cells. Overall, a
general trend of increased invasion was observed in the presence
of stromal cells, with significant increases for PC-3 and PNT2-C2
(Figure 2A).
Metallopeptidase influence on cell invasion
LA Dawson et al
1578
British Journal of Cancer (2004) 90(8), 1577–1582 & 2004 Cancer Research UK
M
o
l
e
c
u
l
a
r
a
n
d
C
e
l
l
u
l
a
r
P
a
t
h
o
l
o
g
yModulation of PC cell line invasion by mitogenic peptide
inactivation
The addition of recombinant NEP resulted in a decrease of
approximately 50% in PC-3 cell invasion in the presence of STO
cells (Figure 2B). The inclusion of thiorphan (1mM), a specific NEP
inhibitor, partially reversed this effect. Thiorphan alone had no
significant effect on invasion when compared with NEP plus
thiorphan (Figure 2B). In the absence of stromal cells, there was no
significant difference in PC-3 invasion between control and treated
wells (data not shown). Similar results were obtained using Du145
cells (data not shown). Inhibition of ECE-1 activity reduced PC-3
invasion by approximately 70% in the presence of stromal cells
(Figure 2C). In the absence of STO, there was no significant change
in the invasive capacity of treated and untreated PC-3 cells (data
not shown). Similar results were obtained for Du145 with ECE-1
inhibition, resulting in a 50% decrease in invasion (Figure 2C).
Effect of mitogenic peptides on cell invasion through
Matrigel
The addition of ET-1 resulted in an increase of approximately 50%
in PC-3 cell invasion through Matrigel in the presence of stromal
cells (Figure 2D). The inclusion of an ECE inhibitor with ET-1
reduced invasion (Figure 2D) by inhibiting endogenous stromal
ECE activity, since no significant effect was observed in the
absence of stromal cells (data not shown). Supplementation with
ET-1 resulted in 100% increase in Du145 invasion through
Matrigel in the presence of stromal cells (Figure 2D). The
simultaneous addition of ET-1 and an ECE inhibitor reduced
invasion to below control levels, but not as much as ECE inhibitor
alone (Figure 2C). Supplementation of serum-free media with the
mitogenic peptide bradykinin increased PC-3 invasion by approxi-
mately 40% in response to indirect co-culture (Figure 2E). The
concomitant addition of bradykinin and ECE-1 inhibitor resulted
in an approximately 70% increase in PC-3 invasion, consistent
with a reduced ability of ECE-1 to inactivate bradykinin. No
significant effect was observed in the absence of stromal cells (data
not shown).
Effects of primary stromal cultures on PC-3 invasion
Endothelin-converting enzyme-1 protein expression was deter-
mined in primary stromal cells derived from malignant and benign
tissue by Western blotting. Higher levels of ECE-1 protein are
expressed in malignant primary stromal cells than in benign
primary stromal cells (Figure 3A). Endothelin-converting enzyme-
1 staining of malignant primary stromal cells was seen as bright
surface membrane and punctate cytoplasmic fluorescence (Figure
3B(2)). Benign and malignant primary stromal cell staining differ
in intensity only (Figure 3B(1)). The effects of either ECE-1
inhibition or recombinant NEP activity on PC-3 invasion in the
presence of malignant and benign primary stromal cells were
examined. Results indicate that stromal cultures from malignant
and benign tissue can stimulate the invasion of PC-3 cells by
approximately 80 and 20%, respectively, beyond the influence of
STO cells (Figure 3C). Endothelin-converting enzyme-1 inhibition
reduced the influence of malignant stroma on PC-3 invasion by
approximately 50%, but had a less significant effect in the presence
of benign stromal cells, reflecting the lower levels of ECE-1 activity
in benign cells. Interestingly, the addition of recombinant NEP
resulted in an approximately 55% and an approximately 40%
decrease in PC-3 invasion in the presence of malignant primary
stroma and benign stroma respectively. This might be anticipated
given that NEP can inactivate a range of peptide mitogens
including ET-1.
DISCUSSION
Many human cancers generate a reactive stroma that promotes
tumour invasion, progression and metastasis. An investigation
into the properties of reactive stroma can reveal considerable
insights into the risk factors for tumorigenicity as reviewed
recently (Tuxhorn et al, 2001). During prostate carcinogenesis, the
stroma undergoes progressive alterations to develop a phenotype
that co-operates with the tumorigenic epithelial cells to help
promote cell motility and invasion (Tuxhorn et al, 2001). Such
alterations include matrix remodelling enzymes (Egeblad and
Werb, 2002). Our study reveals that alterations in the balance of
two membrane-bound metallopeptidases, NEP and ECE-1, can
produce stroma that modulates the invasive potential of prostate
cancer epithelial cells. Endothelin-converting enzyme-1 is ex-
pressed in the stromal compartment, where it generates an active
endothelin (ET-1) peptide and metabolises other peptides includ-
ing bradykinin. A mitogenic role for small regulatory peptides
such as ET has been implicated in PC progression, with elevated
levels found in patients whose tumours have become androgen-
independent (Nelson et al, 1995). Neutral endopeptidase is
expressed in the epithelial layer and functions to cleave and
inactivate a number of small mitogenic peptides, including
ET-1 and bradykinin. In metastatic PC, NEP is dramatically
110 kDa
130 kDa
B
CD
EF
A
NEP
ECE-1
12
Figure 1 (A) Neutral endopeptidase and (B) ECE-1 protein expression
in STO cells. Each lane contains 20mg of membrane protein. Lane 1:
recombinant NEP (10ng) or ECE-1c protein (500ng), positive control.
Lane 2 represents STO cells. Immunofluorescent staining determining
ECE-1 protein expression and subcellular localisation in (C) STO cells,
androgen-independent (D) PC-3 and (E) Du145 cells; (F) NEP protein
expression and subcellular localisation in androgen-sensitive LNCaP cells.
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progression (Papandreou et al, 1998). Here, we have utilised
indirect stromal–epithelial co-culture techniques to demonstrate
the influence of a stromal cell line (STO) and primary stromal
cultures on the ability of metastatic PC cell lines to invade Matrigel
as a consequence of relative NEP and ECE-1 activity. Our data
show that malignant PC-3 and Du145 cells have a greater natural
propensity to invade Matrigel than the transformed but non-
malignant prostate epithelial cell lines PNT2-C2, PNT-1a and P4E6.
This greater propensity is likely due to a host of genetic alterations,
which favour invasion and metastasis. This invasive phenotype can
be further augmented in the presence of stromal cells as a
consequence of their high ECE-1 expression and ET-1 availability
to the tumour. The role of stromal involvement during PC
progression has been reported elsewhere (Lang et al, 2000), and
this is consistent with recent observations that epithelial–stromal
interactions are critical determinants of tumour cell behaviour.
Ramaswamy et al (2003) compared the geneexpression profiles of
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Figure 2 (A) Influence of stromal (STO) cells on invasion of established PC cell lines, PC-3, Du145, and virally transformed prostatic epithelial cell lines,
PNT2-C2, PNT-1a and P4E6 through Matrigel. Error bars represent7s.e.m. of eight fields counted. (B) Invasion of PC-3 cells through Matrigel invasion
chambers in response to the addition of recombinant NEP and thiorphan, a specific NEP inhibitor in the presence of STO. Neutral endopeptidase
(50mgml
1) and thiorphan (1mM) were added to both wells of the invasion chamber containing stromal cells and to the PC-3 cells (810
5) on top of the
Matrigel-coated insert. Each assay was incubated at 371C for 24h. Error bars represent7s.e.m. of eight fields. Data shown are representative of three
separate experiments. *Po0.001, **Po0.005. (C) Invasion of PC-3 and Du145 cells through Matrigel in response to the addition of ECE-specific inhibitor
(ECE-i) (100nM), in the presence of STO. Treatments were added both to the STO on the base of the invasion chamber and to cells (810
5) in the
Matrigel-coated insert. The assay was incubated for 24h. Bars represents the mean value of eight fields counted. Data shown are representative of three
separate experiments. *Po0.001, **Po0.01. (D) Invasion of PC-3 and Du145 cells through Matrigel, following supplementation with ET-1 (10nM) and
ECE-i (100nM) in the presence of stromal cells. Treatments were added to media above and below Matrigel. Each bar represents the mean value of eight
fields counted. Data shown are representative of three separate experiments. *Po0.001, **Po0.01. (E) Invasion of PC-3 cells through Matrigel in response
to the addition of bradykinin (100nM) and the ECE-1 specific inhibitor ECE-i (100nM) in the presence of STO. Treatments were added to the media above
and below Matrigel. PC-3 cells were incubated in defined media for 24h prior to the invasion assay. The assay was incubated for 24h. Each bar represents
the mean value of eight fields counted. Data shown are representative of three separate experiments. **Po0.001, *Po0.005.
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ymetastatic adenocarcinomas with their primary counterparts and
found that a considerable proportion of the refined gene-
expression signature associated with metastasis was derived from
the nonepithelial components of the tumour.
In the rat prostate gland, big-ET, the inactive precursor of ET,
was observed in the stroma and co-localised with a-actin of smooth
muscle fibroblasts (Ventura and Salamoussa, 2002). Endothelin-
converting enzyme-1 has also been shown to co-localise with
a-actin in human vascular smooth muscle cells (Barnes and
Turner, 1999). This implies that ET-1 is synthesised on demand
from bigET in the stroma of the prostate. We have found bigET-1
in primary stromal cells (data not shown). Exogenous ET-1 can
further increase invasion of PC-3 and DU145 in the presence of
stromal cells, and this effect can be partially reversed by inhibiting
endogenous stromal ECE activity, demonstrating the very high
demand of PC cells for mitogenic peptides. Similar results were
observed with the mitogenic peptide bradykinin, an ECE substrate,
with the exception that addition of an ECE-1 inhibitor further
increased invasion by inhibiting ECE hydrolysis of bradykinin.
The most dramatic effect was seen with primary stromal cells of
benign and malignant origin. Our current data on a small number
of samples revealed that indirect co-culture with stromal cultures
from both benign and malignant tissue stimulated the invasion of
PC-3 cells beyond levels previously observed for STO cells.
Furthermore, malignant stroma recruited more invasive epithelial
cells than benign stroma, indicating that the neoplastic process
alters stromal cell activity in such a way as to maximally enhance
invasion. Similar findings have been reported in the motility of
epithelial response to indirect co-culture (Lang et al, 2000).
Immunocytochemical analysis has revealed differences in ECE-1
localisation between PC-3 and DU145 cells and these patterns may
relate to specific isoforms of ECE-1. Any significance of specific
isoforms of ECE in the invasive process is currently being
explored. In contrast to the ECE-1 data, we observed that invasion
of the androgen-independent cell lines PC-3, Du145, could be
decreased by the addition of recombinant NEP and that these
effects could be neutralised by the addition of thiorphan, an NEP-
specific inhibitor. This correlation in PC cells of loss of NEP
expression and cell migration is explained by the catalytic
capability of NEP to inactivate mitogenic peptides such as ET-1
and bradykinin which promote cell migration. This is consistent
with the findings of Suzuki et al (2001) in human endometrial
cancer.
Recent data reveal that NEP has signalling properties indepen-
dent of its enzyme activity (Sumitomo et al, 2000). Could these
signalling properties extend to coordinate ECE expression? Or does
ECE have unique signalling properties of its own? Answers to these
questions are currently being addressed and may provide further
insight into the mechanisms behind the observations reported in
this study.
The current study concludes that downregulation of NEP in
prostate cancer epithelial cells allows mitogenic peptides to impart
growth signals to the developing tumour, while in the surrounding
prostate stroma elevated ECE-1 provides a local source of active
ET-1 which encourages invasion. It may be possible therefore to
inhibit ECE activity in the stroma and suppress the overall growth
of the tumour. Concomitant delivery of recombinant NEP would
neutralise the effects of bradykinin and other peptides and might
result in significant tumour regression. A better understanding of
the relative roles of NEP and ECE in the development, invasion and
progression of prostate tumours will help in the potential design of
useful therapeutic agents to treat prostate cancer.
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